FDA Launches Pilot for Single Day Drug Facility Screenings (2) - news.bloomberglaw.com
FDA initiates a pilot program for single-day drug facility screenings to enhance compliance and efficiency in inspections.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. All pharmaceutical manufacturers subject to FDA inspections. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline mentioned; ongoing participation in the pilot program is implied.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Introduction of a pilot program for expedited, single-day inspections of drug manufacturing facilities.
Who it affects
All pharmaceutical manufacturers subject to FDA inspections.
What you must do
Prepare for potential inspections and ensure compliance with current Good Manufacturing Practices (cGMP).
Deadline
No specific deadline mentioned; ongoing participation in the pilot program is implied.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- CONTROLLED SUBSTANCES—D.D.C.:... - VitalLaw.com
- Vets Plus facility gets FDA greenlight - Morning Ag Clips
- Four more med spa licenses yanked over improper handling of cosmetic drugs - ohiocapitaljournal.com
- AG Yost Helps Secure Lifetime Ban of Martin Shkreli from Pharmaceutical Industry, $65 Million Penalty - ohioattorneygeneral.gov
- Cannabis Industry Attorney Concedes D.C. Circuit Challenge Could Reverse Marijuana Rescheduling - Newswire.com